A Dipeptidyl Peptidase 4 (DPP-4) Inhibitor in Type 1 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2019
Price : $35 *
At a glance
- Drugs Saxagliptin (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 07 Dec 2015 Primary endpoint (Adrenaline levels) has not been met as results published in the Diabetic Medicine.
- 07 Dec 2015 Results published in the Diabetic Medicine
- 17 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.